Brief: ABIONYX Pharma H1 Operating Cash Flow EUR -1.87 Million
26/09/2024 17:40
Sep 26 (Reuters) - ABIONYX Pharma H1 EBIT EUR -2.12 million. * H1 net income EUR -2.09 million
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls